Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0J0MX
|
|||
Former ID |
DNC005847
|
|||
Drug Name |
1,4-diphenyl-(1E,3E)-1,3-butadiene
|
|||
Synonyms |
Bistyryl; 1,4-Diphenyl-1,3-butadiene; 1,4-Diphenylbutadiene; trans,trans-1,4-Diphenyl-1,3-butadiene; 538-81-8; 1,4-Diphenylerythrene; Distyryl; trans,trans-1,4-Diphenylbuta-1,3-diene; (1E,3E)-1,4-Diphenylbuta-1,3-diene; 886-65-7; NSC 122702; 1,4-Diphenylbuta-1,3-diene; UNII-R7P15V6543; 1,1'-(1E,3E)-buta-1,3-diene-1,4-diyldibenzene; 1,3-Butadiene, 1,4-diphenyl-; EINECS 212-952-6; CHEMBL198810; CHEBI:35100; JFLKFZNIIQFQBS-FNCQTZNRSA-N; (4-phenyl-1,3-butadienyl)benzene; R7P15V6543; 1,1'-buta-1,3-diene-1,4-diyldibenzene
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H14
|
|||
Canonical SMILES |
C1=CC=C(C=C1)C=CC=CC2=CC=CC=C2
|
|||
InChI |
1S/C16H14/c1-3-9-15(10-4-1)13-7-8-14-16-11-5-2-6-12-16/h1-14H/b13-7+,14-8+
|
|||
InChIKey |
JFLKFZNIIQFQBS-FNCQTZNRSA-N
|
|||
CAS Number |
CAS 538-81-8
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:35100
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Monoamine oxidase type B (MAO-B) | Target Info | Inhibitor | [1] |
BioCyc | Superpathway of tryptophan utilization | |||
Tryptophan degradation via tryptamine | ||||
Dopamine degradation | ||||
Putrescine degradation III | ||||
Noradrenaline and adrenaline degradation | ||||
KEGG Pathway | Glycine, serine and threonine metabolism | |||
Arginine and proline metabolism | ||||
Histidine metabolism | ||||
Tyrosine metabolism | ||||
Phenylalanine metabolism | ||||
Tryptophan metabolism | ||||
Drug metabolism - cytochrome P450 | ||||
Metabolic pathways | ||||
Serotonergic synapse | ||||
Dopaminergic synapse | ||||
Cocaine addiction | ||||
Amphetamine addiction | ||||
Alcoholism | ||||
Panther Pathway | Adrenaline and noradrenaline biosynthesis | |||
5-Hydroxytryptamine degredation | ||||
Dopamine receptor mediated signaling pathway | ||||
Pathway Interaction Database | Alpha-synuclein signaling | |||
WikiPathways | Tryptophan metabolism | |||
Dopamine metabolism | ||||
Phase 1 - Functionalization of compounds |
References | Top | |||
---|---|---|---|---|
REF 1 | Docking studies on monoamine oxidase-B inhibitors: estimation of inhibition constants (K(i)) of a series of experimentally tested compounds. Bioorg Med Chem Lett. 2005 Oct 15;15(20):4438-46. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.